Severe asthma [SA] is characterized by inadequate control of asthma symptoms and airway physiology despite good therapy, and therefore is associated with impaired response to the most effective agents for asthma management, namely inhaled corticosteroids [ICS]. Dysfunction of the glucocorticoid receptor [GR] is associated with SA, and is in part a consequence of high levels of cytokines associated with Th2 lymphocyte activation, including IL-4. Recent evidence suggests that nitric oxide [NO] may amplify production of IL-4 in the absence of a key anti-inflammatory cytokine, IL-10. We have shown that IL-10 is deficient in asthma, suggesting that NO may be a critical factor in regulating IL-4. Further, the nuclear transcription factor GATA-3 is essential for Th2 lymphocyte differentiation, and its binding to DNA is inhibited by normal GR. To define the mechanisms of SA, we propose (1) to characterize markers of inflammation and remodeling in SA, and compare to mild-moderate asthma [MMA] which is controlled in ICS, (2) to establish the function of the GR in SA and MMA with two complementary techniques, (3) to characterize GATA-3 expression in SA and MMA, (4) to determine the functional consequences of GR dysfunction on cytokine production and co-stimulatory molecule expression, and (5) to establish the mechanisms by which GR dysfunction occurs, with focus on Th2 cytokines, IL-10, and NO. The PI has an established track record of mechanistic investigations in asthma. Twenty patients with SA are already identified, and links to a minority clinic and managed care with >270,000 covered lives will add to our recruitment capabilities. We offer to the collaborative program (1) an established program of clinical, translational, and basic research in asthma, (2) mechanistic studies to evaluate the development of GR dysfunction in SA, and (3) an innovative question of GATA-3 expression in SA.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
1R01HL069130-01
Application #
6436645
Study Section
Special Emphasis Panel (ZHL1-CSR-H (S1))
Program Officer
Noel, Patricia
Project Start
2001-09-20
Project End
2006-06-30
Budget Start
2001-09-20
Budget End
2002-06-30
Support Year
1
Fiscal Year
2001
Total Cost
$495,646
Indirect Cost
Name
University of Pittsburgh
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
053785812
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Wysocki, Kenneth; Park, Seo Young; Bleecker, Eugene et al. (2014) Characterization of factors associated with systemic corticosteroid use in severe asthma: data from the Severe Asthma Research Program. J Allergy Clin Immunol 133:915-8
Witt, Chad A; Sheshadri, Ajay; Carlstrom, Luke et al. (2014) Longitudinal changes in airway remodeling and air trapping in severe asthma. Acad Radiol 21:986-93
Wu, Wei; Bleecker, Eugene; Moore, Wendy et al. (2014) Unsupervised phenotyping of Severe Asthma Research Program participants using expanded lung data. J Allergy Clin Immunol 133:1280-8
Rao, Chitra K; Moore, Charity G; Bleecker, Eugene et al. (2013) Characteristics of perimenstrual asthma and its relation to asthma severity and control: data from the Severe Asthma Research Program. Chest 143:984-992
Li, Xingnan; Hawkins, Gregory A; Ampleford, Elizabeth J et al. (2013) Genome-wide association study identifies TH1 pathway genes associated with lung function in asthmatic patients. J Allergy Clin Immunol 132:313-20.e15
Jarjour, Nizar N; Erzurum, Serpil C; Bleecker, Eugene R et al. (2012) Severe asthma: lessons learned from the National Heart, Lung, and Blood Institute Severe Asthma Research Program. Am J Respir Crit Care Med 185:356-62
Li, Xingnan; Ampleford, Elizabeth J; Howard, Timothy D et al. (2012) Genome-wide association studies of asthma indicate opposite immunopathogenesis direction from autoimmune diseases. J Allergy Clin Immunol 130:861-8.e7
Li, Xingnan; Ampleford, Elizabeth J; Howard, Timothy D et al. (2012) The C11orf30-LRRC32 region is associated with total serum IgE levels in asthmatic patients. J Allergy Clin Immunol 129:575-8, 578.e1-9
Luyster, Faith S; Teodorescu, Mihaela; Bleecker, Eugene et al. (2012) Sleep quality and asthma control and quality of life in non-severe and severe asthma. Sleep Breath 16:1129-37
Hawkins, Gregory A; Robinson, Mac B; Hastie, Annette T et al. (2012) The IL6R variation Asp(358)Ala is a potential modifier of lung function in subjects with asthma. J Allergy Clin Immunol 130:510-5.e1

Showing the most recent 10 out of 30 publications